ABERNETHY MATT bought NBIX
February 13, 2024 · Form 4 insider transaction
ABERNETHY MATT bought 45,058 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,058
Price
$0.00
Total value
N/A
InsiderABERNETHY MATT
RoleDirector
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after45,058
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2024 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.